This topic contains a solution. Click here to go to the answer

Author Question: A client with cardiac arrhythmia is prescribed ibutilide IV. The client weighs 63 kg. The nurse ... (Read 107 times)

bobbie

  • Hero Member
  • *****
  • Posts: 592
A client with cardiac arrhythmia is prescribed ibutilide IV. The client weighs 63 kg. The nurse would expect to administer the drug over which time frame?
 
  A) 1 minute
  B) 5 minutes
  C) 10 minutes
  D) 30 minutes

Question 2

Administration with which of the following would increase serum concentrations of disopyramide? Select all that apply.
 
  A) Amiodarone
  B) Quinidine
  C) Rifampin
  D) Cimetidine
  E) Erythromycin



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jesse.fleming

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

Ans: C
Feedback:
Ibutilide is administered IV over 10 minutes.

Answer to Question 2

Ans: B, E
Feedback:
Increased serum disopyramide levels occur when quinidine or erythromycin is given with disopyramide. Amiodarone and cimetidine increase serum flecainide levels. Rifampin decreases serum disopyramide levels.




bobbie

  • Member
  • Posts: 592
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


atrochim

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

The top five reasons that children stay home from school are as follows: colds, stomach flu (gastroenteritis), ear infection (otitis media), pink eye (conjunctivitis), and sore throat.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library